Combination effects of ellagic acid with erlotinib in a Ba/F3 cell line expressing EGFR H773_V774 insH mutation.

Thoracic Cancer
Chuanqi XieJun Sheng

Abstract

Epidermal growth factor receptor H773_V774 insH (EGFR-insH) is an EGFR exon 20 insertion mutation in non-small cell lung cancer (NSCLC), which is naturally resistant to available EGFR tyrosine kinase inhibitors (TKIs) and lacks a patient-derived cell line. A Ba/F3 cell line expressing EGFR-insH mutation (Ba/F3-insH cell line) was generated using an IL3-deprivation method. A cell proliferation assay was performed to screen natural compounds that exhibit a synergistic effect with erlotinib. Trypan blue staining was used to assess cell growth and crystal violate staining was recruited to evaluate clonogenic potential. Flow cytometry was used to detect EGFR expression and cell apoptosis. A xenograft model was created to evaluate the effect of ellagic acid (EA) with erlotinib on tumor growth. EA was identified to synergistically inhibit the proliferation of Ba/F3-insH cells with erlotinib. The growth and clonogenic potential of Ba/F3-insH cells were definitely constrained by EA with erlotinib, whereas, the apoptosis of Ba/F3-insH cells was dramatically promoted by the combination. In a xenograft model of the Ba/F3-insH cell line, the combination treatment also exhibited a synergistic reduction in tumor growth. In this study, we gene...Continue Reading

References

Mar 3, 2005·Journal of the National Cancer Institute·Hisayuki ShigematsuAdi F Gazdar
Dec 26, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Gregory J RielyWilliam Pao
Apr 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ulrich GatzemeierJoachim Von Pawel
May 15, 2007·Cancer Biology & Therapy·Yuki YuzaMatthew Meyerson
Jul 6, 2007·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Daniel B CostaMark S Huberman
May 7, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lecia V SequistThomas J Lynch
Aug 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jenn-Yu WuPan-Chyr Yang
Oct 23, 2010·Nature Reviews. Cancer·William Pao, Juliann Chmielecki
Sep 21, 2012·Journal of Experimental & Clinical Cancer Research : CR·Samuel MurrayGeorge Fountzilas
Jan 19, 2013·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Geoffrey R OxnardPasi A Jänne
Oct 3, 2013·Oncology Reports·Luca VanellaValeria Sorrenti
Feb 19, 2016·International Journal of Cancer. Journal International Du Cancer·Mengmeng YangQi-Xiang Li
Nov 24, 2016·Nutrients·Claudia CeciGrazia Graziani
Apr 28, 2018·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Bianca van VeggelEgbert F Smit
May 12, 2018·Molecular Cancer Therapeutics·Shinichi HasakoKenichi Matsuo
May 31, 2018·Planta medica·José-Luis RíosM Carmen Recio
Jul 10, 2018·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Jonathan W RiessAlexa B Schrock
Aug 30, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Susan E JorgeDaniel B Costa
Oct 24, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·Z PiotrowskaL V Sequist
Oct 26, 2018·Journal of Cellular and Molecular Medicine·Jing DuanGuang-Biao Zhou
Mar 12, 2019·Signal Transduction and Targeted Therapy·Simon Vyse, Paul H Huang

❮ Previous
Next ❯

Citations

Feb 8, 2022·Journal of Food Biochemistry·Qiwen XiangYan Chen

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft
Transfection
flow cytometry
xenografts

Software Mentioned

FlowJo
GraphPad prism

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis